Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer

AJ Tije; Jaap Verweij; A Sparreboom; Ate van der Gaast; C Fowst; F Fiorentini; J Tursi; A Antonellini; M Mantel; C Hartman; Gerrit Stoter; AST Planting; Maja de Jonge

Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer

AJ Tije, Jaap Verweij, A Sparreboom, Ate van der Gaast, C Fowst, F Fiorentini, J Tursi, A Antonellini, M Mantel, C Hartman, Gerrit Stoter, AST Planting, Maja de Jonge

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2957-2964
Number of pages	8
Journal	Clinical Cancer Research
Volume	9
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

12912942.pdfFinal published version, 88.6 KB

http://hdl.handle.net/1765/10201

Cite this

Tije, AJ., Verweij, J., Sparreboom, A., van der Gaast, A., Fowst, C., Fiorentini, F., Tursi, J., Antonellini, A., Mantel, M., Hartman, C., Stoter, G., Planting, AST., & de Jonge, M. (2003). Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer. Clinical Cancer Research, 9, 2957-2964. http://hdl.handle.net/1765/10201

@article{5d2970cd840042be8796acc27b329c15,

title = "Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer",

author = "AJ Tije and Jaap Verweij and A Sparreboom and {van der Gaast}, Ate and C Fowst and F Fiorentini and J Tursi and A Antonellini and M Mantel and C Hartman and Gerrit Stoter and AST Planting and {de Jonge}, Maja",

year = "2003",

language = "Undefined/Unknown",

volume = "9",

pages = "2957--2964",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

Tije, AJ, Verweij, J, Sparreboom, A, van der Gaast, A, Fowst, C, Fiorentini, F, Tursi, J, Antonellini, A, Mantel, M, Hartman, C, Stoter, G, Planting, AST & de Jonge, M 2003, 'Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer', Clinical Cancer Research, vol. 9, pp. 2957-2964. <http://hdl.handle.net/1765/10201>

TY - JOUR

T1 - Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer

AU - Tije, AJ

AU - Verweij, Jaap

AU - Sparreboom, A

AU - van der Gaast, Ate

AU - Fowst, C

AU - Fiorentini, F

AU - Tursi, J

AU - Antonellini, A

AU - Mantel, M

AU - Hartman, C

AU - Stoter, Gerrit

AU - Planting, AST

AU - de Jonge, Maja

PY - 2003

Y1 - 2003

M3 - Article

VL - 9

SP - 2957

EP - 2964

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

ER -